Letter: Is the Stupp Protocol an Expensive and Unsustainable Standard of Care for Glioblastoma in Low- and Middle-Income Country Settings? A Call to Action!
Neurosurgery
.
2021 Sep 15;89(4):E249-E251.
doi: 10.1093/neuros/nyab273.
Authors
Gideon Adegboyega
1
2
,
Ahmad Ozair
3
,
Ulrick Sidney Kanmounye
2
,
Soham Bandyopadhyay
4
,
Babar Vaqas
5
6
Affiliations
1
Barts and The London School of Medicine and Dentistry Queen Mary University of London London, UK.
2
Research Department Association of Future African Neurosurgeons Yaounde, Cameroon.
3
Faculty of Medicine King George's Medical University Lucknow, India.
4
Oxford University Global Surgery Group Nuffield Department of Surgical Sciences University of Oxford Oxford, UK.
5
Department of Neurosurgery Queens Hospital Romford, UK.
6
Imperial College London London, UK.
PMID:
34318884
DOI:
10.1093/neuros/nyab273
No abstract available
Publication types
Letter
MeSH terms
Dacarbazine
Glioblastoma* / therapy
Humans
Standard of Care
Temozolomide
Substances
Dacarbazine
Temozolomide